Page last updated: 2024-10-24

verapamil and Jactatio Capitis Nocturna

verapamil has been researched along with Jactatio Capitis Nocturna in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Del Mar, CB1
Glasziou, PP1
Spinks, AB1
Sanders, SL1
Hilton, DJ1

Other Studies

1 other study available for verapamil and Jactatio Capitis Nocturna

ArticleYear
Treatment alternatives for nocturnal leg cramps.
    The Medical journal of Australia, 2001, May-21, Volume: 174, Issue:10

    Topics: Aged; Female; Humans; Muscle Cramp; Nafronyl; Quinine; Sleep-Wake Transition Disorders; Verapamil; V

2001